Evidence map›Paper›PMID 32288771›Full record

ReviewDrug discovery today. Disease models2008

Rabbit models of heart disease.

Steven M Pogwizd, Donald M Bers

Abstract readReview
In one paragraph

Review in Drug discovery today. Disease models, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors.Journal of cardiovascular translational research · 2023
    Review
  10. Therapeutic Aspects ofInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Steven M PogwizdDepartments of Medicine, Physiology, and Biophysics & Bioengineering, University of Alabama at Birmingham, Birmingham, AL, United States.
Donald M BersDepartment of Pharmacology, University of California Davis, Genome Building 3513, Davis, CA 95616-8636, United States.

Funding

Program AdministrationP01HL080101 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2006 to 2015
$23.4M
Ca and Na Transport in Heart FailureR01HL064724 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2000 to 2008
$4.4M
Mechanisms of Arrhythmia in the Setting of Heart FailureR01HL046929 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI POGWIZD, STEVEN M · 1998 to 2007
$2.4M
Sex hormones modulate arrhythmogenesis in heart failureR01HL073966 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI POGWIZD, STEVEN M · 2004 to 2007
$1.7M
NHLBI NIH HHS P01 HL080101NHLBI NIH HHS R01 HL046929NHLBI NIH HHS R01 HL064724NHLBI NIH HHS R01 HL073966
6 · The paper itself

Abstract

Human heart disease is a major cause of death and disability. A variety of animal models of cardiac disease have been developed to better understand the etiology, cellular and molecular mechanisms of cardiac dysfunction and novel therapeutic strategies. The animal models have included large animals (e.g. pig and dog) and small rodents (e.g. mouse and rat) and the advantages of genetic manipulation in mice have appropriately encouraged the development of novel mouse models of cardiac disease. However, there are major differences between rodent and human hearts that raise cautions about the extrapolation of results from mouse to human. The rabbit is a medium-sized animal that has many cellular and molecular characteristics very much like human, and is a practical alternative to larger mammals. Numerous rabbit models of cardiac disease are discussed, including pressure or volume overload, ischemia, rapid-pacing, doxorubicin, drug-induced arrhythmias, transgenesis and infection. These models also lead to the assessment of therapeutic strategies which may become beneficial in human cardiac disease.

Identifiers

PMID32288771
PMCPMC7105925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.